8 completed. 8 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 8 |
| Phase 2 | 1 | Completed 1 |
Follow IgA Nephropathy: new trials by email Literature Review of IgA Nephropathy trials Research Report on IgA Nephropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients Placebo, LNP023 - IgA Nephropathy | Phase 3 | Completed | Novartis Pharmaceuticals | 517 | 2021-01-25 | 2026-11-04 |
| Treatment of IgA Nephropathy According to Renal Lesions corticotherapy, Renin Angiotensin system (RAS) blockade or Inhibitors of sodium glucose transporter 2 (SGLT2i) - IgA Nephropathy | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 62 | 2018-02-20 | 2025-11-20 |
| BRIGHT-SC: Blisibimod Response in IgA Nephropathy Following At-Home Treatment by Subcutaneous Administration Blisibimod, Placebo - IgA Nephropathy | Phase 2 / Phase 3 | Completed | Anthera Pharmaceuticals | 57 | 2013-06-01 | 2017-09-18 |
| Aliskiren for Immunoglobulin A (IgA) Nephropathy Aliskiren, Placebo - IgA Nephropathy | Phase 3 | Completed | Chinese University of Hong Kong | 22 | 2009-04-01 | 2012-12-04 |
| Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy supportive therapy with: ACE-inhibitor / ARB / Statin, supportive and immunosuppressive therapy - IgA Nephropathy | Phase 3 | Completed | RWTH Aachen University | 148 | 2008-02-01 | 2015-09-22 |
| Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of Immunoglobulin A Nephropathy Omega-3 fatty acid ethylester90 - IgA Nephropathy | Phase 3 | Completed | Kuhnil Pharmaceutical Co., Ltd. | 152 | 2007-11-01 | 2012-09-27 |
| Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN) irbesartan, methylprednisolone (MP) or prednisone (pred), mycophenolate mofetil (MMF) - IgA Nephropathy | Phase 3 | Completed | Sun Yat-sen University | 151 | 2007-09-01 | 2019-12-03 |
| Steroids and Azathioprine in Advanced IgAN methylprednisolone, azathioprine, prednisone - IgA Nephropathy, Chronic Kidney Disease | Phase 3 | Completed | A. Manzoni Hospital | 46 | 1999-12-01 | 2011-07-13 |
Glomerulonephritis, IGA (8) · Proteinuria (3) · Glomerulonephritis (1) · Kidney Diseases (1) · Renal Insufficiency (1) · Renal Insufficiency, Chronic (1)
Autoimmune Diseases (8) · Female Urogenital Diseases (8) · Female Urogenital Diseases and Pregnancy Complications (8) · Immune System Diseases (8) · Male Urogenital Diseases (8) · Nephritis (8) · Urogenital Diseases (8) · Urologic Diseases (8) · Glomerulonephritis (7) · Kidney Diseases (7) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Urination Disorders (3) · Urological Manifestations (3) · Chronic Disease (1)
Methylprednisolone (2) · Prednisone (2) · AMG623 peptibody (1) · Adenosine Triphosphate (1) · Azathioprine (1) · Hydroxymethylglutaryl-CoA Reductase Inhibitors (1) · Immunosuppression Therapy (1) · Irbesartan (1) · Methylprednisolone Hemisuccinate (1) · Mycophenolic Acid (1) · Omacor (1) · Palliative Care (1) · Renin-Angiotensin System (1) · aliskiren (1) · deltacortene (1)
A. Manzoni Hospital (1) · Anthera Pharmaceuticals (1) · Assistance Publique - Hôpitaux de Paris (1) · Chinese University of Hong Kong (1) · Kuhnil Pharmaceutical Co., Ltd. (1) · Novartis Pharmaceuticals (1) · RWTH Aachen University (1) · Sun Yat-sen University (1)
Germany (3) · South Korea (3) · China (2) · Czechia (2) · France (2) · Hong Kong (2) · Malaysia (2) · Singapore (2) · Taiwan (2) · Thailand (2) · United Kingdom (2) · Argentina (1) · Australia (1) · Belgium (1) · Brazil (1)
Anping Xu, MD (1) · Byung-Joo Park, MD,PhD,FISPE (1) · Jinli Zhang, MD (1) · Juergen Floege, Prof. Dr. (1) · Junzhou Fu, MD (1) · Khalil El Karoui (1) · Li Hao, MD (1) · Menghua Chen, MD (1) · Qinkai Chen, MD (1) · Suhnggwon Kim, Professor (1) · Xueqing Yu, MD (1)
PMID 38299639, PMID 26032537, PMID 37772889, PMID 38864363, PMID 18587715, PMID 23675422, PMID 26630142, PMID 35675911, PMID 37914086, PMID 39453772, PMID 40627446, PMID 41661687, PMID 41910396, PMID 42909451
2016 (1)